Atlas Trials

Long Term Assessment of Post Thrombotic Syndrome : OPTIMEV Study ( SPOT )

Clinical trial NCT03054727 · COMPLETED

Trial details

NCT number
NCT03054727
Sponsor
Association des Médecins Vasculaires Hospitaliers
Status
COMPLETED
Study type
OBSERVATIONAL
Post Thrombotic SyndromeVenous ThromboembolismCardiovascular Diseases
Start date
2017-07-11
Primary completion
2022-12-31
Enrollment
2475

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.